Literature DB >> 29699693

ERK Activation Pathways Downstream of GPCRs.

Ruchi Jain1, Uchenna Watson2, Lakshmi Vasudevan3, Deepak K Saini4.   

Abstract

GPCRs, the 7-TM receptors, represent a class of cell surface receptors which modulate a variety of physiological responses. The serpentine structure in addition to contributing the diversity of stimuli these receptors can sense also provides flexibility to the extracellular and intracellular regions where other proteins can interact with and can form functionally active multimeric entities. The range in signaling and physiological responses generated by these receptors can be attributed to a large repertoire of the receptor subtypes as well as their differential coupling to various classes of G-protein subunits and other proteins which facilitate multistate activation. A multistate GPCR can engage diverse signaling molecules, thereby modulating not only the canonical cellular responses but also noncanonical responses typically associated with activation of other cascades such as RTK and MAPK/ERK signaling. Given the crucial involvement of MAP kinase/ERK signaling in cell fate determination specially with respect to regulating cell proliferation, cellular apoptosis, and survival, GPCR-mediated cross-activation of MAPK has been explored in various systems and shown to involve functional integration of multiple pathways. This review describes the present knowledge of the different mechanisms of ERK activation downstream of GPCRs and our present understanding of receptor-dependent and -independent MAPK activation cascades.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cross talk; ERK; G-protein; MAP kinase; β-Arrestin

Mesh:

Substances:

Year:  2018        PMID: 29699693     DOI: 10.1016/bs.ircmb.2018.02.003

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  21 in total

1.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

2.  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.

Authors:  Shivani Sachdev; Kiran Vemuri; Samuel D Banister; Mitchell Longworth; Michael Kassiou; Marina Santiago; Alexandros Makriyannis; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-12-10       Impact factor: 8.739

3.  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

Authors:  Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446

4.  Roles of early events in the modifications undergone by bovine corneal endothelial cells during wound healing.

Authors:  Cristian Justet; Julio A Hernández; Silvia Chifflet
Journal:  Mol Cell Biochem       Date:  2022-06-21       Impact factor: 3.396

5.  Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.

Authors:  Lijuan Ma; Fan Yang; Xiang Wu; Chunyou Mao; Lulu Guo; Tianshu Miao; Shao-Kun Zang; Xiaoyu Jiang; Dan-Dan Shen; Tianhui Wei; Hengxing Zhou; Qin Wei; Shiyang Li; Qiang Shu; Shiqing Feng; Changtao Jiang; Bo Chu; Lutao Du; Jin-Peng Sun; Xiao Yu; Yan Zhang; Pengju Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-15       Impact factor: 12.779

Review 6.  ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses.

Authors:  Deborah A Lannigan
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

7.  Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

8.  Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms.

Authors:  Emily C Wheeler; Shailee Vora; Daniel Mayer; Andriana G Kotini; Malgorzata Olszewska; Samuel S Park; Ernesto Guccione; Julie Teruya-Feldstein; Lewis Silverman; Roger K Sunahara; Gene W Yeo; Eirini P Papapetrou
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

9.  Blocked metabotropic glutamate receptor 5 enhances chemosensitivity in hepatocellular carcinoma and attenuates chemotoxicity in the normal liver by regulating DNA damage.

Authors:  Hui-Min Yang; Tian-Zhong Hou; Ya-Nan Zhang; Shu-Dong Zhao; Yong-Le Wu; Hong Zhang
Journal:  Cancer Gene Ther       Date:  2022-04-08       Impact factor: 5.854

Review 10.  cROStalk for Life: Uncovering ROS Signaling in Plants and Animal Systems, from Gametogenesis to Early Embryonic Development.

Authors:  Valentina Lodde; Piero Morandini; Alex Costa; Irene Murgia; Ignacio Ezquer
Journal:  Genes (Basel)       Date:  2021-04-03       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.